Umeh CA, Stratton A, Wagner T, Saigal S, Sood K, Dhawan R, Wagner C, Obi J, Kumar S, Ching THS, Gupta R. Use of intravascular lithotripsy in non-coronary artery lesions. World J Cardiol 2023; 15(8): 395-405 [PMID: 37771339 DOI: 10.4330/wjc.v15.i8.395]
Corresponding Author of This Article
Chukwuemeka Anthony Umeh, MD, Attending Doctor, Internal Medicine, Hemet Global Medical Center, 1117 E Devonshire Avenue, Hemet, CA 92543, United States. emmyumeh@gmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Systematic Reviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Chukwuemeka Anthony Umeh, Ashley Stratton, Tifani Wagner, Shipra Saigal, Krystal Sood, Raghav Dhawan, Cory Wagner, Jessica Obi, Tsung Han Scottie Ching, Internal Medicine, Hemet Global Medical Center, Hemet, CA 92543, United States
Sabina Kumar, Department of Cardiology, Mclaren Macomb-Oakland/Michigan State University, Macomb, MI 48043, United States
Rahul Gupta, Internal Medicine, University of California, San Diego, CA 92122, United States
Author contributions: All authors conceptualized and revised the study design; Stratton A, Wagner T, Saigal S, Sood K, Dhawan R, and Wagner C extracted the data; Umeh CA analyzed the data; Umeh CA and Gupta R wrote the first draft of the paper; Ching THS, Kumar S, Obi J, Gupta R, and Umeh CA reviewed and revised the paper; Stratton A led and coordinated the research and writing of the manuscript; Scottie C, Gupta R, and Umeh CA supervised the project; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chukwuemeka Anthony Umeh, MD, Attending Doctor, Internal Medicine, Hemet Global Medical Center, 1117 E Devonshire Avenue, Hemet, CA 92543, United States. emmyumeh@gmail.com
Received: March 12, 2023 Peer-review started: March 12, 2023 First decision: June 15, 2023 Revised: June 25, 2023 Accepted: July 24, 2023 Article in press: July 24, 2023 Published online: August 26, 2023 Processing time: 162 Days and 3.1 Hours
ARTICLE HIGHLIGHTS
Research background
Peripheral arterial disease (PAD) is a common manifestation of atherosclerotic disease globally, and heavy calcifications in peripheral artery diseases reduce the success of endovascular therapy for PAD. Intravascular lithotripsy (IVL) has emerged as a technique for plaque modification of severely calcified artery lesions.
Research motivation
Most of the focus of IVL has been on treating coronary artery diseases, and its use in peripheral arteries has not been extensively studied.
Research objectives
To analyze the use of IVL in the peripheral arteries, its safety, and efficacy, as reported in case reports.
Research methods
We searched and extracted cases from PubMed, EMBASE, and Reference Citation Analysis databases. Then, we did a quantitative and qualitative analysis of case reports on IVL use in peripheral artery diseases.
Research results
IVL was successfully and safely used in heavily calcified lesions in the iliofemoral artery, aortic arch and necks arteries, mesenteric arteries, renal arteries, and aorta, with the iliofemoral artery being the commonest site reported. Adverse effects were minimal, but the most severe was reported in IVL use in the neck arteries.
Research conclusions
IVL has been safely used in a broadening array of complex, severely calcified peripheral artery disease lesions.
Research perspectives
More extensive studies are needed to assess the safety of IVL in peripheral artery vessels, such as the aortic arch and necks arteries, where it is not currently approved for use.
